ArticleFrontiers in immunology2026
IgG and IgM responses to PfEMP1 domains associated with semi-immunity to clinical malaria in Burkinabe children under five.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Malaria remains a major global health burden, with children under five years in sub-Saharan Africa disproportionately affected. While immunity develops with repeated exposure, the specific correlates of protection in early childhood are not well defined. To address this, we assessed IgG and IgM antibody responses to Methods: Using AlphaScreen, we measured antibody responses to 271 PfEMP1 (3D7) domains expressed via wheat germ cell-free synthesis. Results: Pre-season analysis showed that 96% of domains were IgG-reactive and IgG breadth increased with age, whereas 71% were IgM-reactive, but IgM breadth showed no age trend. IgG responses to 132 domains (49%) remained significantly associated with reduced risk of clinical malaria after false discovery rate (FDR) correction, including many non-adhesion domains. Five (5) IgM responses were nominally protective, but none remained significant after FDR correction. Fc-dependent opsonic phagocytosis assay using a subset of the top-ranked domains revealed that opsonic phagocytosis activity correlated with protection for only one antigen, suggesting that PfEMP1-specific antibodies may mediate protection through mechanisms beyond phagocytosis in children under 5 years old. Conclusions: This study provides the first comprehensive characterization of IgG and IgM responses to a large panel of PfEMP1 domains in young children, revealing broad antibody recognition and selective opsonic phagocytosis activity. Findings from the study deepen our understanding of early-life immunity to malaria and help identify PfEMP1 regions of interest for future vaccine development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.